| 8888888 | N/A | 8 | 60 | 8,900 | $400 | $9.5M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 17 | 30 | 1,760 | $50 | $1.6M |
| J3490 | Unclassified drugs | 12 | 30 | 150 | $90 | $520.6K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 4 | 10 | 70 | $30 | $407K |
| T1015 | Clinic visit/encounter, all-inclusive | 22 | 70 | 270 | $110 | $376.1K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 18 | 70 | 1,610 | $30 | $367.9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 10 | 20 | 270 | $40 | $334.7K |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 13 | 160 | 190 | $70 | $283.2K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 15 | 190 | 200 | $50 | $239.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 22 | 40 | 770 | $90 | $231.9K |